The Gross Margin of Jenburkt Pharmaceuticals Ltd (524731.BO) is 80.45%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 80.45% |
| 2024-03-31 | 77.54% |
| 2023-03-31 | 74.72% |
| 2022-03-31 | 73.64% |
| 2021-03-31 | 71.69% |
| 2020-03-31 | 71.26% |
| 2019-03-31 | 69.30% |
| 2018-03-31 | 70.36% |
| 2017-03-31 | 70.42% |
| 2016-03-31 | 70.42% |